Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Pharma — Distribution. Per the activity note to the FY2024 annual report, the company engages in wholesale trade of pharmaceutical products. Based in Tbilisi's Isani district; founded by Gogita Mebonia and Irakli Mebonia.
| Ratio | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross Margin | 24.2% | 19.7% | 21.2% | 26.6% | 23.2% | 26.0% | 30.9% | 32.3% |
| EBITDA Margin | 19.4% | 15.0% | 17.9% | 23.2% | 20.0% | 21.5% | 24.4% | 24.4% |
| EBITDAR | 453 | 414 | 527 | 786 | 745 | 743 | 910 | 880 |
| EBITDAR Margin | 20.5% | 15.9% | 18.7% | 23.9% | 20.7% | 22.3% | 25.7% | 25.7% |
| EBIT Margin | 19.0% | 14.8% | 17.5% | 22.8% | 19.7% | 21.3% | 24.3% | 24.3% |
| Net Profit Margin | 17.0% | 13.0% | 15.9% | 18.4% | 17.7% | 20.4% | 20.3% | 18.3% |
| Operating Expense % of Sales | 4.7% | 4.7% | 3.3% | 3.4% | 3.2% | 4.5% | 6.4% | 8.0% |
| Returns | ||||||||
| Return on Assets (ROA) | 30.6% | 25.3% | 29.0% | 31.9% | 29.4% | 33.3% | 37.7% | 31.7% |
| Return on Equity (ROE) | 30.7% | 33.3% | 35.7% | 43.4% | 35.6% | 33.5% | 38.0% | 36.2% |
| ROIC [EBIT / Invested Capital] | 34.5% | 43.5% | 39.9% | 64.7% | 39.9% | 35.5% | 47.1% | 56.7% |
| Leverage & debt balances | ||||||||
| Debt-to-Assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Debt-to-Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt-to-EBITDA | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Equity-to-Assets | 99.8% | 76.0% | 81.2% | 73.6% | 82.5% | 99.4% | 99.0% | 87.6% |
| Net Debt | -12 | -137 | -18 | -238 | -4 | -30 | -67 | -264 |
| Cash & Equivalents | 12 | 137 | 18 | 238 | 4 | 30 | 67 | 264 |
| Total Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Liquidity & working capital | ||||||||
| Current Ratio | 414.44x | 4.07x | 5.10x | 3.68x | 5.59x | 152.95x | 103.33x | 7.95x |
| Quick Ratio | 414.44x | 4.07x | 0.11x | 0.51x | 0.06x | 152.95x | 103.33x | 7.95x |
| Cash Ratio | 22.75x | 0.43x | 0.06x | 0.47x | 0.01x | 2.27x | 3.68x | 1.07x |
| Total Current Assets | 222 | 1,311 | 1,478 | 1,848 | 2,124 | 2,008 | 1,887 | 1,952 |
| Total Current Liabilities | 1 | 322 | 290 | 502 | 380 | 13 | 18 | 246 |
| Inventory | N/A | N/A | 1,447 | 1,591 | 2,101 | N/A | N/A | N/A |
| Trade Receivables | 210 | 5 | 12 | 15 | 11 | 64 | 29 | 79 |
| Trade Payables | 1 | 319 | 290 | 477 | 366 | 1 | 0 | 245 |
| Net Working Capital | 221 | 989 | 1,188 | 1,346 | 1,744 | 1,995 | 1,869 | 1,707 |
| Net Working Capital % of Revenue | 10.0% | 38.1% | 42.2% | 40.9% | 48.4% | 59.8% | 52.7% | 49.9% |
| Trade Working Capital | 209 | -314 | 1,169 | 1,129 | 1,746 | 63 | 29 | -166 |
| Trade Working Capital % of Revenue | 9.5% | -12.1% | 41.5% | 34.4% | 48.5% | 1.9% | 0.8% | -4.9% |
| Change in Trade Working Capital | N/A | -523 | 1,483 | -40 | 617 | -1,683 | -34 | -195 |
| Turnover & efficiency | ||||||||
| Inventory Turnover | N/A | N/A | 1.53x | 1.52x | 1.32x | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A | 238.1 | 240.7 | 277.2 | N/A | N/A | N/A |
| Receivables Turnover | 10.53x | 489.41x | 230.50x | 218.80x | 330.39x | 52.26x | 122.15x | 43.34x |
| Days Sales Outstanding (DSO) | 34.7 | 0.7 | 1.6 | 1.7 | 1.1 | 7.0 | 3.0 | 8.4 |
| Payables Turnover | 3128.09x | 6.53x | 7.65x | 5.06x | 7.56x | 3855.59x | 11681.67x | 9.44x |
| Days Payable Outstanding (DPO) | 0.1 | 55.9 | 47.7 | 72.2 | 48.3 | 0.1 | 0.0 | 38.7 |
| Cash Conversion Cycle | 34.5 days | -55.2 days | 192.0 days | 170.2 days | 230.1 days | 6.9 days | 3.0 days | -30.2 days |
| Asset Turnover | 1.80x | 1.94x | 1.82x | 1.73x | 1.66x | 1.63x | 1.85x | 1.73x |
| Cash flow & dividends | ||||||||
| Operating Cash Flow | N/A | 2,909 | 2,820 | 662 | 20 | 519 | 854 | 1,016 |
| Free Cash Flow (OCF − Capex proxy) | N/A | 631 | 71 | 662 | 20 | 519 | 854 | 1,016 |
| Cash Conversion (OCF / EBITDA) | N/A | 745.7% | 560.7% | 86.9% | 2.8% | 72.3% | 98.5% | 121.7% |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set.